Safety and Immune Responses After Vaccination With an Investigational RNA-based Vaccine Against Malaria
Clinical trial NCT05581641 · COMPLETED
Trial details
- NCT number
- NCT05581641
- Sponsor
- BioNTech SE
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-15
- Primary completion
- 2024-02-23
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.